Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage neuromuscular disease company focused on advancing life-transforming therapeutics for people living with genetically driven diseases, today ...

Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...

Alpha-GPC, a choline-rich supplement, enhances brain health by increasing acetylcholine, with potential applications in ...

Much progress has been made in diabetes technology over the past decade. Continuous glucose monitoring has achieved high accuracy and reliability, resulting ...

By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...

Cancer-free for nearly 20 years, RIT graduate student Bryona Hamilton seeks to educate patients, survivors, and family ...

Reconstructive surgery, essential for restoring function and appearance after trauma or disease, has undergone significant transformation due to ...

Cleveland Clinic’s Travis Tyson discusses the potential of AI and the opportunity to maximize existing building footprints to ...

Make data more insightful with free, online, collaborative spreadsheets. Microsoft Copilot in Excel unlocks the latest AI capabilities to help you achieve your goals—from creating a simple spreadsheet ...